Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Personality Characteristics in Ms Patients: The Role of Avoidant Personality Publisher Pubmed



Mohamadi A1 ; Davoodimakinejad M1 ; Azimi A2 ; Nafissi S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, North Karegar Street, Tehran, 14114, Iran

Source: Clinical Neurology and Neurosurgery Published:2016


Abstract

Objectives Quality of life (QOL) is markedly affected by multiple sclerosis (MS). Particular personality characteristics (PC) of MS patients can affect their QOL. We designed the present study to determine the role of various PCs on QOL in MS patients accounting for other clinical factors. Methods QOL, PC, physical disability, and mental status were recorded in 83 MS patients referred to two academic hospitals of Tehran University of Medical Sciences in 2011-2012. Results The mean age of enrolled patients was 31.54 ± 7.38 (range: 14-50) years and 74 (89.2%) were female. Mean disease duration was 4.55 ± 4.70 years. Seventy-seven patients (92.8%) had relapsing-remitting disease, five (6%) had primary progressive, and one showed a secondary progressive course. Correlation between total QOL scores in MS patients and disease duration, cognitive impairment, and physical disability was significant (all p < 0.001). Obsessive-compulsive personality was the most frequent PC (43.4%) in our patients. Only avoidant personality had a significant negative correlation with all components of QOL (Beta: 0.33, p < 0.00). In addition, avoidant personality, physical disability, and mental status were found to be three predictors of QOL with all its components. Conclusion Avoidant personality appears to be an important predictor of poor QOL in MS patients. In addition, avoidant coping strategies appear to be associated with adverse response to stressful events in these patients. These findings suggest the need for psychological intervention for improving the coping strategies and QOL in MS patients. © 2016 Published by Elsevier B.V.
Related Docs
View other Related Docs
1. Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies, Neurologic Clinics (2016)
2. Association of Cognitive Impairment and Quality of Life in Patients With Multiple Sclerosis: A Cross-Sectional Study, Current Journal of Neurology (2022)
3. Quality of Life and Cognitive Emotion Regulation Strategies in Multiple Sclerosis Patients, Journal of Rational - Emotive and Cognitive - Behavior Therapy (2023)
4. Validity and Reliability of the Persian Version of Recce Stigma Scale in People With Multiple Sclerosis and Its Impact on Quality of Life, BMC Neurology (2024)
5. Channelopathy-Related Scn10a Gene Variants Predict Cerebellar Dysfunction in Multiple Sclerosis, Neurology (2016)
6. Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity), Multiple Sclerosis and Related Disorders (2024)
7. Stem Cell Therapy for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
8. Deficiency in Mental Rotation of Upper and Lower-Limbs in Patients With Multiple Sclerosis and Its Relation With Cognitive Functions, Acta Medica Iranica (2016)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (21)
Mohammad Hossein Harirchian (6)
Other Related Docs
9. Demographic Features, Behavioral Measures, and Clinical Factors As Predictors of Cognitive Function in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
10. Plp1 Mutations in Patients With Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations, Journal of Clinical Medicine (2018)
11. Dietary Inflammatory Index and Risk of Multiple Sclerosis: Findings From a Large Population-Based Incident Case–Control Study, Clinical Nutrition (2020)
12. Age and Sex Adjusted Prevalence and Annual Incidence of Multiple Sclerosis in East-Azerbaijan, Iran, Multiple Sclerosis and Related Disorders (2021)
13. Prevalence and Predictors of Dysphagia in Iranian Patients With Multiple Sclerosis, Medical Journal of the Islamic Republic of Iran (2017)
14. The Epidemiologic Trend of Multiple Sclerosis in Razavi Khorasan Province, Iran in Fifteen-Year Period, Multiple Sclerosis and Related Disorders (2025)
15. Safety and Efficacy of Memantine for Multiple Sclerosis-Related Fatigue: A Pilot Randomized, Double-Blind Placebo-Controlled Trial, Journal of the Neurological Sciences (2020)
16. Validation of the Persian Version of the Dysphagia in Multiple Sclerosis Questionnaire for the Assessment of Dysphagia in Multiple Sclerosis, Journal of Research in Medical Sciences (2019)
17. Utility of Myelin Basic Protein As an Early Prognostic Biomarker in Multiple Sclerosis, Iranian Red Crescent Medical Journal (2017)
18. The Role of the Cerebellum in Multiple Sclerosis, Cerebellum (2015)
19. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients With Multiple Sclerosis: A Study of Diagnostic Accuracy, Archives of Clinical Neuropsychology (2023)
20. Smoking and Worsening Disability in Multiple Sclerosis: A Meta-Analysis, Acta Neurologica Scandinavica (2018)
21. Parental Ethnicity Associated With Risk for Multiple Sclerosis: A Population-Based Incident Case–Control Study in Iran, Multiple Sclerosis and Related Disorders (2018)
22. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
23. Differential Serostatus of Epstein-Barr Virus in Iranian Ms Patients With Various Clinical Patterns, Medical Journal of the Islamic Republic of Iran (2018)
24. Effects of Eight-Week Resistance Training Program in Men With Multiple Sclerosis, Asian Journal of Sports Medicine (2015)
25. Functional Clinical Outcomes in Multiple Sclerosis: Current Status and Future Prospects, Multiple Sclerosis and Related Disorders (2015)
26. The Role of Cerebellar Abnormalities in Neuromyelitis Optica - a Comparison With Multiple Sclerosis and Healthy Controls, Multiple Sclerosis (2015)
27. Dysregulation of Micrornas Regulating Survivin in Cd4+ T Cells in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2020)
28. Biomechanical Changes of the Common Carotid Artery and Internal Jugular Vein in Patients With Multiple Sclerosis, Ultrasonography (2023)
29. Effectiveness of Sexual Counseling Using Better Model to Promote Sexual Function and Satisfaction of Married Women With Multiple Sclerosis, Sexuality and Disability (2022)
30. Multiple Sclerosis Walking Scale-12, Translation, Adaptation and Validation for the Persian Language Population, Gait and Posture (2015)
31. The Forgotten Tract of Vision in Multiple Sclerosis: Vertical Occipital Fasciculus, Its Fiber Properties, and Visuospatial Memory, Brain Structure and Function (2022)
32. Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Subcutaneous Interferon Β-1A in Iran, International Journal of Neuroscience (2017)
33. Thalamic Shape Abnormalities in Patients With Multiple Sclerosis-Related Fatigue, NeuroReport (2021)
34. The Association of Ebv and Hhv-6 Viral Load With Different Nk and Cd8+ T Cell Subsets in the Acute Phase of Relapsing-Remitting Multiple Sclerosis, Cell Journal (2021)
35. Effectiveness of Acupuncture for Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial, Acupuncture in Medicine (2023)
36. Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis, Neuroepidemiology (2015)
37. Fluoxetine for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
38. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review, Neuroepidemiology (2016)
39. Effects of Acupuncture on Cognitive Functions in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial, Chinese Journal of Integrative Medicine (2025)
40. Phase-Synchrony Evaluation of Eeg Signals for Multiple Sclerosis Diagnosis Based on Bivariate Empirical Mode Decomposition During a Visual Task, Computers in Biology and Medicine (2020)
41. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
42. The Effect of Rituximab on the Cognitive Function of Patients With Relapsing-Remitting Multiple Sclerosis, Clinical Therapeutics (2024)
43. Impact of Melatonin on Motor, Cognitive and Neuroimaging Indices in Patients With Multiple Sclerosis, Iranian Journal of Allergy# Asthma and Immunology (2015)
44. Occupational and Individual Factors Associated With Return to Work in Workers With Multiple Sclerosis; [Multipl Sklerozlu Iscilerde Ise Donus Ile Iliskili Mesleki Ve Bireysel Faktorler], Turk Noroloji Dergisi (2022)
45. Genetic Polymorphisms and Epigenetic Regulation of Survivin Encoding Gene, Birc5, in Multiple Sclerosis Patients, BMC Immunology (2019)
46. An Interleukin 12 B Single Nucleotide Polymorphism Increases Il-12P40 Production and Is Associated With Increased Disease Susceptibility in Patients With Relapsing-Remitting Multiple Sclerosis, Neurological Research (2017)
47. Lifetime Physical Activity Is Associated With Gut Bacteria and Brain Health in People With Multiple Sclerosis: Focus on Physical Activity Intensity, Multiple Sclerosis and Related Disorders (2022)
48. Potential Efficacy of Caffeine Ingestion on Balance and Mobility in Patients With Multiple Sclerosis: Preliminary Evidence From a Single-Arm Pilot Clinical Trial, PLoS ONE (2024)
49. Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis, Multiple Sclerosis Journal (2019)
50. Efficacy and Safety of Jollab Monzej As a Traditional Persian Compound Medicine for the Treatment of Multiple Sclerosis-Related Fatigue: A Randomized Placebo-Controlled Trial, Caspian Journal of Internal Medicine (2023)